Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Xeris Biopharma Holdings Q1 EPS $(0.14) Misses $(0.12) Estimate, Sales $40.64M Miss $41.81M Estimate

Author: Benzinga Newsdesk | May 09, 2024 07:05am

Xeris Biopharma Holdings (NASDAQ:XERS) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 16.67 percent decrease over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $40.64 million which missed the analyst consensus estimate of $41.81 million by 2.80 percent. This is a 22.42 percent increase over sales of $33.20 million the same period last year.

Posted In: XERS